龙灯瑞迪制药WeChat
龙灯瑞迪制药
龙灯瑞迪制药 Language
龙灯瑞迪制药
EN CN
Product Name: Pazopanib Tablets
Product Name: Pazopanib Tablets
Products Name:Product Name: Pazopanib Tablets
Trade Name: 万希卫®
Indications: This product is indicated for the first line treatment of patients with advanced renal cell carcinoma and for the treatment of patients with advanced renal cell carcinoma who have received prior cytokine therapy.
Strength: 0.2 g
Approval Number: National Drug Approval No. H20253053
View Package Insert
This content is only available to healthcare professionals. Non professionals can click 'Cancel'
Cancel
Confirm